D-Cycloserine Augmentation of Cognitive-Behavioral Therapy: Directions for Pilot Research in Pediatric Obsessive-Compulsive Disorder
Authors:
- 22 January 2010
- journal article
- research article
- Published by Springer Nature in Child & Youth Care Forum
- Vol. 39 (2) , 101-112
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Evidence-Based Psychosocial Treatments for Child and Adolescent Obsessive–Compulsive DisorderJournal of Clinical Child & Adolescent Psychology, 2008
- A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorderMolecular Psychiatry, 2006
- Potentials and Limitations of Cognitive Treatments for Obsessive‐Compulsive DisorderCognitive Behaviour Therapy, 2005
- Cognitive-Behavioral Family Treatment of Childhood Obsessive-Compulsive Disorder: A Controlled TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2004
- The Glutamatergic System and Alzheimer???s DiseaseCNS Drugs, 2003
- Treatment Compliance and Outcome in Obsessive-Compulsive DisorderBehavior Modification, 2002
- Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trialBehaviour Research and Therapy, 2002
- The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning.Behavioral Neuroscience, 1996
- Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell culturesBrain Research, 1993
- Scoring the Social Phobia and Anxiety Inventory: Comments on Herbertet al. (1991)Journal of Psychopathology and Behavioral Assessment, 1992